| Vorinostat | IC50 | 90.1 [1] |
| Vorinostat | Ki | 5.0 [1], 12.0 [2], 29.0 [3], 36.0 [4] |
| Trichostatin A | IC50 | 10.32 [1] |
| Trichostatin A | Ki | 0.5 [1], 0.58 [2] |
| Entinostat | IC50 | 501.0 [1] |
| Entinostat | Ki | 360.0 [1] |
| Panobinostat | IC50 | 2.1 [1] |
| Panobinostat | Ki | 1.1 [1], 2.3 [2], 2.4 [3] |
| Mocetinostat | IC50 | 1165.0 [1] |
| Mocetinostat | Ki | 265.0 [1] |
| Tubastatin A | IC50 | 30000.0 [1] |
| Apicidin | IC50 | 0.6 [1], 2.5 [2], 9.7 [3], 29.0 [4] |
| Apicidin | Ki | 0.26 [1] |
| Dacinostat | IC50 | 0.4 [1], 3.6 [2], 9.0 [3], 10.5 [4] |
| Dacinostat | Ki | 4.2 [1] |
| Largazole | IC50 | 604.0 [1] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 398.0 [1], 10000.0 [2], 20000.0 [3] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | Ki | 500.0 [1] |
| Tubacin | IC50 | 630.0 [1], 1270.0 [2] |
| Tubacin | Ki | 275.0 [1], 544.3 [2] |
| Belinostat | IC50 | 46.0 [1] |
| Belinostat | Ki | 1.5 [1], 19.0 [2] |
| Romidepsin | IC50 | 1.3 [1], 62.0 [2] |
| Romidepsin | Ki | 0.15 [1] |
| Tacedinaline | IC50 | 1200.0 [1], 100000.0 [2] |
| Tacedinaline | Ki | 550.0 [1] |
| Ricolinostat | IC50 | 51.0 [1], 135.0 [2] |
| N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide | IC50 | 30000.0 [1], 50000.0 [2] |
| Largazole Thiol | IC50 | 0.7 [1], 3.4 [2] |
| CID 25023797 | IC50 | 560.0 [1], 1200.0 [2] |
| CID 25023798 | IC50 | 9400.0 [1] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-(2-methylpropyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 100.0 [1], 102.0 [2], 175.05 [3] |
| 5-Cyclopropyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 108.24 [1], 260.0 [2], 262.0 [3] |
| Scriptaid | IC50 | 100.0 [1] |
| Scriptaid | Ki | 4.1 [1] |
| Abexinostat | Ki | 8.2 [1], 10.0 [2] |
| Quisinostat | Ki | 2.1 [1], 4.3 [2] |
| n,n'-Dihydroxyoctanediamide | IC50 | 62600.0 [1] |
| n,n'-Dihydroxyoctanediamide | Ki | 125.0 [1] |
| Givinostat | Ki | 3.0 [1] |
| HDAC6 Inhibitor | IC50 | 0.42 [1], 190.0 [2] |
| N-Hydroxy-4-phenylbutanamide | IC50 | 2000.0 [1] |
| N-Hydroxy-4-phenylbutanamide | Ki | 1650.0 [1] |
| N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide | IC50 | 60.0 [1], 300.0 [2] |
| 4-[2-[2-Hydroxyethyl(Phenyl)amino]-2-Oxidanylidene-Ethyl]-~{n}-Oxidanyl-Benzamide | IC50 | 1700.0 [1] |
| N-(2-Aminophenyl)-4-[1-[2-(3-thienyl)ethyl]-1H-1,2,3-triazol-4-yl]benzamide | IC50 | 240.0 [1], 3940.0 [2] |
| N'-Hydroxy-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamide | IC50 | 7.2 [1] |
| CID 24853793 | IC50 | 120.0 [1], 122.0 [2] |
| CID 24857909 | IC50 | 670.0 [1] |
| N-Hydroxy-6-[(2S,5S,8S,11S)-8-(1H-indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanamide | IC50 | 8.0 [1], 18.0 [2] |
| N-(4-Hydroxybiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
| 6-[(2S,5S,8S,11S)-2-Benzyl-8-(1H-indol-3-ylmethyl)-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]-N-hydroxyhexanamide | IC50 | 31.0 [1] |
| 6-[(2S,5S,8S,11S)-2-Methyl-11-(2-methylpropyl)-8-(naphthalen-1-ylmethyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acid | IC50 | 990.0 [1] |
| (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 12.0 [1], 12.5 [2] |
| (2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamide | IC50 | 11.0 [1] |
| CID 15984018 | IC50 | 230.0 [1] |
| (S)-Benzyl 4-(5-(2-aminophenylcarbamoyl)pyridin-2-yl)-2-methylpiperazine-1-carboxylate | IC50 | 939.0 [1], 942.0 [2] |
| N-(2-Amino-5-thiophen-2-ylphenyl)-4-methoxybenzamide | IC50 | 20000.0 [1] |
| (5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione | IC50 | 0.7 [1], 2.78 [2] |
| 1-[5-(2,3-Dihydro-1H-indol-1-ylcarbonyl)thiophen-2-yl]-2,2,2-trifluoroethan-1-one | IC50 | 1400.0 [1], 1700.0 [2] |
| (E)-3-(1'-Benzyl-4-oxospiro[3H-chromene-2,4'-piperidine]-6-yl)-N-hydroxyprop-2-enamide | IC50 | 9.4 [1], 65.0 [2] |
| 1-[5-[3-[4-(1,3,4-Oxadiazole-2-yl)phenoxymethyl]-1,2,4-oxadiazole-5-yl]-2-thienyl]trifluoroethanone | IC50 | 380.0 [1], 1000.0 [2] |
| 6-[(2S,5S,8S,11S)-2-(4-Aminobutyl)-11-(2-methylpropyl)-8-(naphthalen-1-ylmethyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acid | IC50 | 240.0 [1], 242.0 [2] |
| N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide | IC50 | 46000.0 [1] |
| (E)-3-[1'-[(4-Fluorophenyl)methyl]-4-oxospiro[3H-chromene-2,4'-piperidine]-6-yl]-N-hydroxyprop-2-enamide | IC50 | 90.0 [1], 92.0 [2] |
| (E)-N-Hydroxy-3-[4-oxo-1'-(2-phenylethyl)spiro[3H-chromene-2,4'-piperidine]-6-yl]prop-2-enamide | IC50 | 130.0 [1] |
| N-[(2S)-1-[4-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]-2-methoxyphenoxy]-3-(1H-indol-3-yl)propan-2-yl]-2-propylpentanamide | IC50 | 7.5 [1], 280.0 [2] |
| N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide | IC50 | 4500.0 [1] |
| (1R,5S)-N-[2-Amino-5-(4-fluorophenyl)phenyl]-8-oxabicyclo[3.2.1]octane-3-carboxamide | IC50 | 2280.0 [1], 13700.0 [2] |
| [(E)-5-Sulfanylpent-2-enyl] (2S)-3-methyl-2-[[2-(1,3-thiazol-4-yl)-1,3-thiazole-4-carbonyl]amino]butanoate | IC50 | 58.0 [1], 60.0 [2] |
| [(E)-5-Sulfanylpent-2-enyl] (2S)-3-methyl-2-[[2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazole-4-carbonyl]amino]butanoate | IC50 | 106.0 [1], 110.0 [2] |
| [(E)-5-Octanoylsulfanylpent-2-enyl] (2S)-3-methyl-2-[[2-(1,3-thiazol-4-yl)-1,3-thiazole-4-carbonyl]amino]butanoate | IC50 | 2830.0 [1], 2831.0 [2] |
| [(E)-5-Octanoylsulfanylpent-2-enyl] (2S)-3-methyl-2-[[2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazole-4-carbonyl]amino]butanoate | IC50 | 3558.0 [1], 3560.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 107.0 [1], 110.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-methyl-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 620.0 [1], 691.0 [2] |
| 5-Ethyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 256.0 [1], 260.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-propan-2-yl-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 358.0 [1], 360.0 [2] |
| 5-Butyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 188.0 [1], 190.0 [2] |
| 5-Ethenyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 380.0 [1], 384.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-[(E)-3-methylbut-1-enyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 140.0 [1], 142.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-[(E)-prop-1-enyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 106.0 [1], 110.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-(2-hydroxy-2-methylpropyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 2203.0 [1], 2590.0 [2] |
| 5-Cyclohexyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 325.0 [1], 330.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-(2-propan-2-ylcyclopropyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 276.0 [1], 280.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-phenyl-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 377.0 [1], 380.0 [2] |
| 5-(4-Fluorophenyl)-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 310.0 [1], 314.0 [2] |
| 5-(2-Chlorophenyl)-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 450.0 [1], 453.0 [2] |
| 5-(2-Chloro-4-fluorophenyl)-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 587.0 [1], 590.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-(4-nitrophenyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 200.0 [1], 201.0 [2] |
| 5-Benzyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 79.0 [1], 80.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-5-(2-phenylmethoxyethyl)-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | IC50 | 158.0 [1], 160.0 [2] |
| N-[(2S)-1-[[4-(Hydroxyamino)-4-oxobutyl]amino]-3-methyl-1-oxobutan-2-yl]-2-(1,3-thiazol-4-yl)-1,3-thiazole-4-carboxamide | IC50 | 1638.0 [1], 1640.0 [2] |
| N-[(2S)-1-[[3-(Hydroxyamino)-3-oxopropyl]amino]-3-methyl-1-oxobutan-2-yl]-2-(1,3-thiazol-4-yl)-1,3-thiazole-4-carboxamide | IC50 | 3136.0 [1], 3170.0 [2] |
| N-[(2S)-1-[[3-(Hydroxyamino)-3-oxopropyl]amino]-3-methyl-1-oxobutan-2-yl]-2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazole-4-carboxamide | IC50 | 2218.0 [1], 2220.0 [2] |
| N-[(2S)-1-[[4-(Hydroxyamino)-4-oxobutyl]amino]-3-methyl-1-oxobutan-2-yl]-2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazole-4-carboxamide | IC50 | 1577.0 [1], 1580.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-4-yl)-1,3-thiazole-4-carboxamide | IC50 | 193.0 [1], 270.0 [2] |
| N-[5-(Hydroxyamino)-5-oxopentyl]-2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazole-4-carboxamide | IC50 | 150.0 [1], 615.0 [2] |
| N-[[4-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]cyclohexyl]methyl]-4,4-dimethyl-2-oxo-1,3-dihydroquinoline-6-carboxamide | IC50 | 15.0 [1], 370.0 [2] |
| N-[[4-[3-(Hydroxyamino)-3-oxopropyl]cyclohexyl]methyl]-4,4-dimethyl-2-oxo-1,3-dihydroquinoline-6-carboxamide | IC50 | 87.0 [1], 89.0 [2] |
| Valproic acid | IC50 | 161000.0 [1] |